High-Flow Nasal Cannula versus Noninvasive Positive Pressure Ventilation in Patients with Heart Failure after Extubation: An Observational Cohort Study.
Aged
Airway Extubation
/ adverse effects
Cannula
Female
Heart Failure
/ diagnosis
Humans
Male
Noninvasive Ventilation
/ instrumentation
Outcome and Process Assessment, Health Care
Positive-Pressure Respiration
/ instrumentation
Respiratory Insufficiency
/ diagnosis
Retreatment
/ methods
Stroke Volume
Taiwan
/ epidemiology
Treatment Failure
Ventricular Function, Left
Journal
Canadian respiratory journal
ISSN: 1916-7245
Titre abrégé: Can Respir J
Pays: Egypt
ID NLM: 9433332
Informations de publication
Date de publication:
2020
2020
Historique:
received:
22
02
2020
revised:
24
04
2020
accepted:
06
05
2020
entrez:
28
7
2020
pubmed:
28
7
2020
medline:
29
6
2021
Statut:
epublish
Résumé
Noninvasive positive pressure ventilation (NPPV) has been widely applied in patients with high-risk extubation failure, including heart failure. High-flow nasal cannula (HFNC) has been demonstrated to benefit patients with heart failure by reducing cardiac preload. This study aimed to compare the effectiveness of HFNC to NPPV for preventing extubation failure in patients with heart failure. This 3-year retrospective and single-center cohort study included patients with heart failure with left ventricular ejection fraction <50% who received prophylactic HFNC or NPPV after scheduled extubation from January 2015 to January 2018 from a medical center with four adult intensive care units. Demographics, comorbidities, diagnosis, and weaning status were collected. The primary outcome was treatment failure within 72 hours after extubation, which was defined as escalation to NPPV or reintubation in the HFNC group and was defined as requiring reintubation in the NPPV group. Secondary outcomes were reintubation within 72 hours, reintubation, duration of stay, and mortality during the intensive care unit and hospital stay. Of the 104 patients analyzed, characteristics of 58 patients in the HFNC group and 46 patients in the NPPV group were compared. The treatment failure within 72 hours in the two groups was not significantly different (25.9% vs 13%,
Identifiants
pubmed: 32714476
doi: 10.1155/2020/6736475
pmc: PMC7354657
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
6736475Informations de copyright
Copyright © 2020 Che-Jung Chang et al.
Déclaration de conflit d'intérêts
The authors declare that there are no conflicts of interest.
Références
Respir Med. 2016 Dec;121:100-108
pubmed: 27888983
Crit Care. 2016 Feb 26;20:48
pubmed: 26926168
J Card Fail. 2012 Dec;18(12):912-8
pubmed: 23207079
Ann Emerg Med. 2017 Oct;70(4):465-472.e2
pubmed: 28601264
Crit Care Med. 2005 Nov;33(11):2465-70
pubmed: 16276167
Intensive Care Med. 2016 Jan;42(1):82-92
pubmed: 26464393
Am J Respir Crit Care Med. 2013 Jul 15;188(2):220-30
pubmed: 23631814
Am J Respir Crit Care Med. 2006 Jan 15;173(2):164-70
pubmed: 16224108
J Intensive Care Med. 2018 Nov;33(11):609-623
pubmed: 28429603
Clin Sci (Lond). 1995 Feb;88(2):173-8
pubmed: 7720341
Crit Care. 2005;9(6):607-21
pubmed: 16356246
N Engl J Med. 2015 Jun 4;372(23):2185-96
pubmed: 25981908
Eur Respir J. 2017 Aug 31;50(2):
pubmed: 28860265
Crit Care Med. 2011 Dec;39(12):2612-8
pubmed: 21765357
World J Cardiol. 2014 Nov 26;6(11):1175-91
pubmed: 25429330
Respir Care. 2015 Oct;60(10):1377-82
pubmed: 26060321
JAMA. 2016 Oct 18;316(15):1565-1574
pubmed: 27706464
Respir Care. 2015 Oct;60(10):1397-403
pubmed: 26329355
Respir Care. 2012 Feb;57(2):204-10
pubmed: 21762554
J Crit Care. 2013 Oct;28(5):741-6
pubmed: 23602035
Am J Respir Crit Care Med. 2013 Jun 15;187(12):1294-302
pubmed: 23641924
Am J Respir Crit Care Med. 2017 May 1;195(9):1207-1215
pubmed: 27997805
JAMA. 2015 Jun 16;313(23):2331-9
pubmed: 25980660
Crit Care. 2016 Apr 28;20(1):109
pubmed: 27121707
BMC Anesthesiol. 2014 Aug 07;14:66
pubmed: 25110463
Crit Care Med. 2015 Mar;43(3):613-20
pubmed: 25479115
BMJ Open Respir Res. 2017 Jul 20;4(1):e000200
pubmed: 29071075
Chest. 1997 Jul;112(1):186-92
pubmed: 9228375
Respir Care. 2016 Apr;61(4):529-41
pubmed: 27016353
J Intensive Care Med. 2017 Jan 1;:885066616689043
pubmed: 28110612
N Engl J Med. 2008 Jul 10;359(2):142-51
pubmed: 18614781
Respiration. 2008;76(4):393-7
pubmed: 18679015
Cochrane Database Syst Rev. 2013 May 31;(5):CD005351
pubmed: 23728654
Chest. 2017 Jan;151(1):166-180
pubmed: 27818331